Article
Exploring the impact of Durvalumab on biliary tract cancer- insights from real world clinical data
2024-09-10
Abstract excerpt
<title>Abstract</title> <p><bold>Introduction</bold> This study assesses the effectiveness of durvalumab with platinum and gemcitabine for biliary tract cancers (BTC). It aims to confirm the Topaz-1 trial results in a real-world context and explore the link between BTC molecular profiles and patient outcomes. <bold>Methods</bold> A retrospective analysis was conducted on 102 BTC patients treated with durvalumab,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6af6db68-6873-5bc4-8407-b98e86f03c1f
- DOI
- 10.21203/rs.3.rs-4840712/v1
